| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Harold I Feldman | Q104285977 |
| John W Kusek | Q114079290 | ||
| Josef Coresh | Q30436517 | ||
| Christopher H. Schmid | Q50923597 | ||
| Marc Froissart | Q51543851 | ||
| P2093 | author name string | Andrew S Levey | |
| Frederick Van Lente | |||
| Lesley A Stevens | |||
| Tom Greene | |||
| Yaping Lucy Zhang | |||
| Robert D Bruce | |||
| Jerome Rossert | |||
| P2860 | cites work | Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate | Q53846526 |
| Simplified calculation of body-surface area. | Q55060911 | ||
| The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease | Q56867091 | ||
| Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study | Q68540938 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate | Q72711726 | ||
| Serum cystatin C as a marker of glomerular filtration rate | Q79279423 | ||
| Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls | Q79428212 | ||
| Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients | Q28201830 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Chronic kidney disease in the elderly--how to assess risk | Q28251559 | ||
| Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement | Q28256758 | ||
| Thyroid function differently affects serum cystatin C and creatinine concentrations | Q28257633 | ||
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | Q28257707 | ||
| Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans | Q28262338 | ||
| Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program | Q28285436 | ||
| Thyroid function differently affects serum cystatin Cand creatinine concentrations | Q29395175 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Cystatin C--properties and use as diagnostic marker. | Q34065634 | ||
| Assessing kidney function--measured and estimated glomerular filtration rate | Q34535861 | ||
| Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 | ||
| Cystatin C. | Q34584709 | ||
| Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial | Q44218873 | ||
| Serum cystatin C in the aged: relationships with health status | Q44493971 | ||
| Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? | Q44550988 | ||
| A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate | Q44588682 | ||
| Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. | Q44801998 | ||
| Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values | Q45119840 | ||
| Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. | Q45230608 | ||
| Cystatin C concentration as a risk factor for heart failure in older adults | Q46421474 | ||
| Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. | Q46551488 | ||
| Kidney function as a predictor of noncardiovascular mortality | Q46776022 | ||
| Glomerular filtration rate estimated by cystatin C among different clinical presentations | Q46891109 | ||
| Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. | Q51911823 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 395-406 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD | |
| P478 | volume | 51 |
| Q33612113 | 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function |
| Q36980376 | 24-hour urine phosphorus excretion and mortality and cardiovascular events |
| Q50902375 | A Study of the Applicability of GFR Evaluation Equations for an Elderly Chinese Population. |
| Q57791871 | A comparison between 2017 FAS and 2012 CKD-EPI equations: a multi-center validation study in Chinese adult population |
| Q51315864 | A comparison between serum creatinine and cystatin C-based equations for estimation of graft function. |
| Q36843484 | A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. |
| Q35025446 | A comparison of cystatin C- and creatinine-based prediction equations for the estimation of glomerular filtration rate in black South Africans |
| Q34495570 | A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection |
| Q34326854 | A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate |
| Q58587760 | A model for Glomerular filtration Rate Assessment In Liver disease (GRAIL) in the presence of renal dysfunction |
| Q34457191 | A multi-marker approach to predict incident CKD and microalbuminuria |
| Q90340235 | A multi-source data integration approach reveals novel associations between metabolites and renal outcomes in the German Chronic Kidney Disease study |
| Q24651973 | A new equation to estimate glomerular filtration rate |
| Q46478748 | A proinflammatory diet is associated with systemic inflammation and reduced kidney function in elderly adults |
| Q37048746 | A prospective controlled study of kidney donors: baseline and 6-month follow-up |
| Q30528010 | A prospective study of frailty in nephrology-referred patients with CKD. |
| Q51356367 | Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes. |
| Q21558546 | Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies |
| Q38070393 | Accuracy of cystatin C-based estimates of glomerular filtration rate in kidney transplant recipients: a systematic review. |
| Q47567601 | Accuracy of glomerular filtration rate estimationequations in patients with hematopathy. |
| Q34217710 | Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults |
| Q35334993 | Advances in glomerular filtration rate-estimating equations |
| Q26853272 | Advances in the use of multimarker panels for renal risk stratification |
| Q28750345 | Age and cystatin C in healthy adults: a collaborative study |
| Q92096169 | Agreement and Precision Analyses of Various Estimated Glomerular Filtration Rate Formulae in Cancer Patients |
| Q34455130 | Albuminuria and the risk of incident stroke and stroke types in older adults |
| Q42215011 | Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia |
| Q34169632 | Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease |
| Q43195092 | Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. |
| Q51529734 | Analytical performances of cystatin C turbidimetric assay: which impact on accuracy of glomerular filtration rate estimation in renal transplantation? |
| Q51172231 | Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis. |
| Q37417971 | Apolipoprotein E and kidney function in older adults. |
| Q51317671 | Are cystatin C-based equations superior to creatinine-based equations for estimating GFR in Chinese elderly population? |
| Q37330539 | Arterial stiffness in mild-to-moderate CKD |
| Q35985772 | Assessing glomerular filtration rate in hospitalized patients: a comparison between CKD-EPI and four cystatin C-based equations |
| Q30636047 | Assessment of renal function; clearance, the renal microcirculation, renal blood flow, and metabolic balance |
| Q38768281 | Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study |
| Q55519177 | Association between baseline kidney function and change in CRP: an analysis of the cardiovascular health study. |
| Q36532736 | Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging |
| Q37357864 | Association between free light chain levels, and disease progression and mortality in chronic kidney disease |
| Q84587482 | Association between habitual coffee consumption and normal or increased estimated glomerular filtration rate in apparently healthy adults |
| Q36555620 | Association between kidney function and telomere length: the heart and soul study |
| Q36796594 | Association between physical performance and all-cause mortality in CKD |
| Q47158694 | Association between serum cystatin C and bone mineral density in Korean adults. |
| Q36796589 | Association between younger age when first overweight and increased risk for CKD. |
| Q37603716 | Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). |
| Q34149313 | Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q36423854 | Association of Serum Erythropoietin With Cardiovascular Events, Kidney Function Decline, and Mortality: The Health Aging and Body Composition Study |
| Q37412696 | Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality |
| Q38415397 | Association of advanced age with concentrations of uraemic toxins in CKD. |
| Q36652825 | Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study |
| Q36770261 | Association of cardiac troponin T with left ventricular structure and function in CKD. |
| Q33562005 | Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). |
| Q33932292 | Association of cystatin C with adverse outcomes. |
| Q34660044 | Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis |
| Q36079687 | Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study |
| Q51307137 | Association of low 25-hydroxyvitamin D levels with the frailty syndrome in an aged population: results from the KORA-age Augsburg study. |
| Q33932951 | Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis |
| Q35624204 | Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q33598417 | Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis |
| Q34629690 | Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States |
| Q35056658 | Association of serum bicarbonate levels with gait speed and quadriceps strength in older adults |
| Q37248990 | Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study |
| Q30503036 | Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study |
| Q33617174 | Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study |
| Q35154207 | Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study |
| Q95510702 | Association of urinary uromodulin with kidney function decline and mortality: the health ABC study |
| Q34828514 | Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women |
| Q36947333 | Association of visceral and subcutaneous adiposity with kidney function |
| Q30433474 | Associations between genetic variants in the ACE, AGT, AGTR1 and AGTR2 genes and renal function in the Multi-ethnic Study of Atherosclerosis |
| Q36280359 | Associations between kidney function and subclinical cardiac abnormalities in CKD. |
| Q35133155 | Associations of acculturation and kidney dysfunction among Hispanics and Chinese from the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q23915594 | Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations |
| Q23920030 | Associations of multiple metals with kidney outcomes in lead workers |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q35875497 | Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q35026256 | B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study |
| Q43237776 | Biological variation of cystatin C and creatinine |
| Q92922094 | Biomarker panels associated with progression of renal disease in type 1 diabetes |
| Q38212008 | Biomarkers in cardiorenal syndromes |
| Q28087304 | Biomarkers in chronic kidney disease, from kidney function to kidney damage |
| Q38290083 | Biomarkers in diabetic nephropathy: Present and future |
| Q52665457 | Biomarkers of diabetic kidney disease. |
| Q28392186 | Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis |
| Q37315355 | Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. |
| Q37276155 | Blood pressure components and decline in kidney function in community-living older adults: the Cardiovascular Health Study |
| Q46220838 | Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease |
| Q36523333 | Calciotropic hormones and the risk of hip and nonspine fractures in older adults: the Health ABC Study |
| Q34340185 | Cardiac Troponin I elevation after epileptic seizure |
| Q34532094 | Cardiorenal syndrome type 2: from diagnosis to optimal management |
| Q36471339 | Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy |
| Q37051996 | Change in Measured GFR Versus eGFR and CKD Outcomes |
| Q52671258 | Changes in Blood Pressure During Young Adulthood and Subsequent Kidney Function Decline: Findings From the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study. |
| Q87393507 | Chapter 1: Definition and classification of CKD |
| Q40139225 | Chemical analog-to-digital signal conversion based on robust threshold chemistry and its evaluation in the context of microfluidics-based quantitative assays |
| Q34631631 | Chronic kidney disease |
| Q35176802 | Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance |
| Q35175515 | Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study |
| Q34169626 | Chronic kidney disease and venous thromboembolism: a prospective study |
| Q51849496 | Chronic kidney disease definition and classification: no need for a rush to judgment. |
| Q35030634 | Chronic kidney disease in octogenarians |
| Q35116672 | Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study |
| Q36843411 | Chronic kidney disease prevalence estimates among racial/ethnic groups: the Multi-Ethnic Study of Atherosclerosis |
| Q35860706 | Chronic kidney disease, insulin resistance, and incident diabetes in older adults. |
| Q44821800 | Chronic kidney disease: Cystatin-C-based eGFR: what is it telling us? |
| Q82714331 | Chronic kidney disease: Endogenous filtration markers--is it time to move beyond eGFR? |
| Q35804154 | Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes |
| Q37900798 | Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). |
| Q36250267 | Clinical Decision Making in a Patient with Stage 5 CKD--Is eGFR Good Enough? |
| Q64271637 | Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention |
| Q34161893 | Clinical usefulness of serum cystatin C as a marker of renal function |
| Q35104582 | Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial |
| Q42681134 | Cohort profile: the chronic kidney disease prognosis consortium |
| Q88594607 | Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease |
| Q36638809 | Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q36652786 | Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes |
| Q37641171 | Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women |
| Q34079762 | Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. |
| Q44842416 | Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients |
| Q35903122 | Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals |
| Q40783894 | Comparison Between CKD-EPI Creatinine and MDRD Equations to Estimate Glomerular Filtration Rate in Kidney Transplant Patients |
| Q33608612 | Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians |
| Q40725063 | Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome. |
| Q35665877 | Comparison of Various Equations for Estimating GFR in Malawi: How to Determine Renal Function in Resource Limited Settings? |
| Q37680650 | Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease |
| Q35088150 | Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease |
| Q35566332 | Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. |
| Q92506846 | Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes |
| Q45936050 | Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease. |
| Q90364758 | Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV |
| Q35466376 | Correlates of insulin resistance in older individuals with and without kidney disease |
| Q37652161 | Correlation analysis between eGFRcys and SXscore in patients with diabetes |
| Q36786414 | Correlation of cystatin C and creatinine based estimates of renal function in children with hydronephrosis |
| Q88177124 | Correlation of the Glomerular Filtration Rate Measured With the Use of DTPA-Tc99m in Live Kidney Donors With Equations Based on Creatinine and Cystatin C |
| Q92658895 | Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study |
| Q58723613 | Creatinine-Based Renal Function Estimates and Dosage of Postoperative Pain Management for Elderly Acute Hip Fracture Patients |
| Q33811643 | Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis |
| Q51598157 | Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients. |
| Q55008547 | Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury. |
| Q59101867 | Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus |
| Q34614924 | Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q37171386 | Cystatin C and frailty in older men. |
| Q64328935 | Cystatin C and galectin-3 as therapeutic targets in heart failure |
| Q36821470 | Cystatin C and risk of hip fractures in older women |
| Q33855997 | Cystatin C and sudden cardiac death risk in the elderly |
| Q50624187 | Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus. |
| Q37616789 | Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease |
| Q34539983 | Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes |
| Q33631221 | Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients |
| Q51621252 | Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. |
| Q34457290 | Cystatin C identifies chronic kidney disease patients at higher risk for complications |
| Q36345739 | Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events |
| Q47563513 | Cystatin C is Indispensable for Evaluation of Kidney Disease |
| Q51630513 | Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies. |
| Q44532809 | Cystatin C is better than albuminuria as a predictor of pulse wave velocity in hypertensive patients |
| Q42906280 | Cystatin C is not a better estimator of GFR than plasma creatinine in the general population |
| Q37501912 | Cystatin C is not a good candidate biomarker for HNF1A-MODY. |
| Q37176789 | Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. |
| Q35189962 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons |
| Q37364907 | Cystatin C, albuminuria, and mortality among older adults with diabetes. |
| Q42803609 | Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions |
| Q49041943 | Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients |
| Q35133144 | Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance |
| Q36712221 | Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials |
| Q37660880 | Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. |
| Q36869663 | Cystatin C--a paradigm of evidence based laboratory medicine. |
| Q41636688 | Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability |
| Q48338108 | Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure. |
| Q40822108 | Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients |
| Q37856794 | Cystatin C: a step forward in assessing kidney function and cardiovascular risk |
| Q37313436 | Cystatin C: current position and future prospects |
| Q37112901 | Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration |
| Q33937027 | Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women |
| Q43072840 | Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. |
| Q38749511 | Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients. |
| Q36971461 | Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality |
| Q35134400 | Diabetes and coronary heart disease as risk factors for mortality in older adults |
| Q33583018 | Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis |
| Q34228586 | Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment |
| Q46253453 | Diagnosis and follow-up of chronic kidney graft dysfunction: from DFG to new biomarkers |
| Q36409145 | Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate |
| Q34629709 | Dietary fiber, kidney function, inflammation, and mortality risk |
| Q35535820 | Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. |
| Q44805897 | Different association of cigarette smoking with GFR estimated from serum creatinine and that from serum cystatin C in the general population |
| Q43280925 | Different equations to combine creatinine and cystatin C to predict GFR. Arithmetic mean of existing equations performs as well as complex combinations. |
| Q35528586 | Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes. |
| Q34527591 | Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index |
| Q43109634 | Discrepancies between creatinine- and cystatin C-based equations: implications for identification of chronic kidney disease in the general population |
| Q46218097 | Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population |
| Q34257105 | Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial |
| Q34796627 | Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? |
| Q41148547 | Early Acute Kidney Injury based on Serum Creatinine or Cystatin C in Intensive Care Unit after Major Trauma |
| Q92085478 | Early changes in pulmonary function and intrarenal haemodynamics and the correlation between these sets of parameters in patients with T2DM |
| Q35938045 | Early chronic kidney disease: diagnosis, management and models of care |
| Q37728653 | Early recognition and prevention of chronic kidney disease |
| Q35692447 | Early renal function decline in type 2 diabetes |
| Q64965105 | Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy. |
| Q34983153 | Effect of enhanced external counterpulsation treatment on renal function in cardiac patients |
| Q87353510 | Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study |
| Q34292912 | Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial |
| Q33602077 | Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy |
| Q44232525 | Emerging importance of residual renal function in end-stage renal failure |
| Q37339484 | Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. |
| Q36410394 | Epidemiology and Public Health Concerns of CKD in Older Adults |
| Q34497226 | Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration |
| Q26864498 | Established and emerging markers of kidney function |
| Q90288079 | Estimated GFR: time for a critical appraisal |
| Q42276788 | Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injury |
| Q51333288 | Estimated glomerular filtration rate from serum cystatin C: significant differences among several equations results. |
| Q35030559 | Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins |
| Q34406428 | Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease |
| Q37464727 | Estimated glomerular filtration rate: time for a performance review? |
| Q53166992 | Estimated glomerular filtration rates cannot replace measured GFR in type 1 diabetes patients with hyperfiltration. |
| Q37276263 | Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study |
| Q33634956 | Estimated visceral adipose tissue, but not body mass index, is associated with reductions in glomerular filtration rate based on cystatin C in the early stages of chronic kidney disease |
| Q34289794 | Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study |
| Q33756494 | Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions |
| Q47839918 | Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome |
| Q35429171 | Estimating glomerular filtration rate from serum creatinine and cystatin C. |
| Q34068775 | Estimating glomerular filtration rate in a population-based study |
| Q35819414 | Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker |
| Q51373011 | Estimating the glomerular filtration rate using serum cystatin C levels in patients with spinal cord injuries. |
| Q42875455 | Estimation of Glomerular Filtration Rate by Using Serum Cystatin C and Serum Creatinine Concentrations in Patients with Human Immunodeficiency Virus |
| Q36414936 | Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. |
| Q34448835 | Estimation of glomerular filtration rate from serum creatinine and cystatin C in octogenarians and nonagenarians. |
| Q37826129 | Estimation of glomerular filtration rate: what are the pitfalls? |
| Q35564754 | Evaluating the performance of equations for estimating glomerular filtration rate. |
| Q51463577 | Evaluation of creatinine, cystatin C and eGFR by different equations in professional cyclists during the Giro d'Italia 3-weeks stage race. |
| Q50643798 | Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients. |
| Q90702698 | Evaluation of monitoring methods in asymptomatic dogs with high serum cystatin C concentrations |
| Q51412419 | Evaluation of serum creatinine- and cystatin C-based equations for the estimation of glomerular filtration rate in a Chinese population. |
| Q43566904 | Evaluation of the serum cystatin C values in prediction of indications for hemodialysis in patients with chronic renal failure. |
| Q36069564 | Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus |
| Q38010263 | Exercise training in chronic kidney disease patients. |
| Q35107128 | Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England |
| Q35574977 | Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values |
| Q53189719 | FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. |
| Q36849302 | Factors Associated with Higher Pro-Inflammatory Tumor Necrosis Factor-α Levels in Young Women with Type 1 Diabetes |
| Q36020086 | Factors other than glomerular filtration rate affect serum cystatin C levels |
| Q31132279 | Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level |
| Q35479461 | Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study |
| Q36782677 | Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study |
| Q38998962 | Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults |
| Q88284298 | Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline |
| Q37071263 | Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study |
| Q36476324 | Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. |
| Q37342971 | Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults |
| Q37589683 | Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study |
| Q36095111 | Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). |
| Q33988990 | Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study |
| Q35715869 | Filtration markers may have prognostic value independent of glomerular filtration rate |
| Q33734661 | Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease |
| Q36719260 | Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes |
| Q43241952 | Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease |
| Q35985709 | GFR decline and mortality risk among patients with chronic kidney disease |
| Q37726985 | GFR estimation: from physiology to public health |
| Q35206146 | Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure). |
| Q35058803 | Gender disparity in liver transplant waiting-list mortality: the importance of kidney function |
| Q30277642 | Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function |
| Q36263854 | Genome-Wide Association of Copy Number Polymorphisms and Kidney Function |
| Q34220999 | Genome-wide association and functional follow-up reveals new loci for kidney function |
| Q26825851 | Genome-wide association studies of chronic kidney disease: what have we learned? |
| Q36849928 | Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin |
| Q51529199 | Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations? |
| Q37901050 | Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations |
| Q37591529 | Glomerular filtration rate measurement and prediction equations. |
| Q42795456 | Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study |
| Q37051743 | HIV viremia and changes in kidney function |
| Q22306345 | Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association |
| Q22306356 | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association |
| Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
| Q29547236 | Heart disease and stroke statistics--2011 update: a report from the American Heart Association |
| Q29547909 | Heart disease and stroke statistics--2012 update: a report from the American Heart Association |
| Q29547691 | Heart disease and stroke statistics--2014 update: a report from the American Heart Association |
| Q91828497 | Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects |
| Q40656900 | High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD. |
| Q33873169 | High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up |
| Q35112086 | Higher biomarker-calibrated protein intake is not associated with impaired renal function in postmenopausal women. |
| Q36317393 | Higher plasma transforming growth factor (TGF)-β is associated with kidney disease in older community dwelling adults |
| Q64083562 | Higher serum uric acid level is inversely associated with renal function assessed by cystatin C in a Japanese general population without chronic kidney disease: the KOBE study |
| Q34221216 | How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology |
| Q37980388 | How to manage HIV-infected patients with chronic kidney disease in the HAART era. |
| Q36604880 | Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study |
| Q37603096 | Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the ludwigshafen risk and cardiovascular health study |
| Q34334349 | Implementation of automated reporting of estimated glomerular filtration rate among Veterans Affairs laboratories: a retrospective study |
| Q36900935 | Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations |
| Q35755932 | Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine. |
| Q47565094 | Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion? |
| Q40990382 | Independent associations of vitamin D metabolites with anemia in patients referred to coronary angiography: the LURIC study |
| Q28387350 | Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q34021333 | Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study |
| Q34405328 | Influence of age and measure of eGFR on the association between renal function and cardiovascular events |
| Q37361808 | Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study |
| Q51539276 | Influence of thyroid function on different kidney function tests. |
| Q36584486 | Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study |
| Q35976473 | Insulin resistance, cystatin C, and mortality among older adults |
| Q37970042 | Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician. |
| Q38412301 | Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial |
| Q51152056 | Iothalamate versus estimated GFR in a Hispanic-dominant pediatric renal transplant population. |
| Q51442980 | Is the Chronic Kidney Disease Epidemiology Collaboration four-level race equation better than the cystatin C equation? |
| Q35883140 | Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study |
| Q50326085 | Kidney Disease: Personalized Lifestyle Health Care Makes a Big Difference |
| Q35827309 | Kidney dysfunction and cognitive decline in women |
| Q37518114 | Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars |
| Q33804430 | Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis |
| Q37359040 | Kidney function and prevalent and incident frailty |
| Q35576334 | Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). |
| Q37285963 | Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. |
| Q46009914 | Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease. |
| Q35055095 | Kidney function, β-cell function and glucose tolerance in older men. |
| Q35573216 | Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort. |
| Q47920631 | Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3. |
| Q37002467 | Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA) |
| Q37093147 | Lipoprotein-associated phospholipase A2 and venous thromboembolism: a prospective study |
| Q33829301 | LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells |
| Q37328747 | Long-Term Effects of a Very Low Carbohydrate Compared With a High Carbohydrate Diet on Renal Function in Individuals With Type 2 Diabetes: A Randomized Trial |
| Q34751900 | Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. |
| Q46019200 | Longitudinal blood pressure changes and kidney function decline in persons without chronic kidney disease: Findings from the MESA study. |
| Q37810410 | Low Agreement between the Modified Diet and Renal Disease Formula and the Cockcroft-Gault Formula for Assessing Chronic Kidney Disease in Cognitively Impaired Elderly Outpatients |
| Q40572760 | Low glomerular filtration rate as an associated risk factor for sarcopenic muscle strength: is creatinine or cystatin C-based estimation more relevant? |
| Q53638477 | Low serum tryptophan predicts higher mortality in cardiovascular disease. |
| Q34607577 | Low-level cadmium exposure and effects on kidney function |
| Q51036859 | Lower glomerular filtration rate is associated with higher systemic vascular resistance in patients without prevalent kidney disease. |
| Q50961980 | Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome. |
| Q36702716 | Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly |
| Q35053281 | Markers of mineral metabolism are not associated with aortic pulse wave velocity in community-living elderly persons: the Health Aging and Body Composition study |
| Q35272304 | Measured GFR does not outperform estimated GFR in predicting CKD-related complications |
| Q37639626 | Measuring vs estimating glomerular filtration rate in kidney transplantation. |
| Q34629623 | Metabolic abnormalities are present in adults with elevated serum cystatin C |
| Q37367733 | Method of glomerular filtration rate estimation affects prediction of mortality risk |
| Q89985568 | MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update |
| Q36083364 | Microvascular and Macrovascular Abnormalities and Cognitive and Physical Function in Older Adults: Cardiovascular Health Study |
| Q35101778 | Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study |
| Q36244797 | Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Tromsø study |
| Q37750515 | Monitoring renal function: measured and estimated glomerular filtration rates - a review |
| Q34633964 | Multicenter study of creatinine- and/or cystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease |
| Q28943262 | Multiple loci associated with indices of renal function and chronic kidney disease |
| Q49097109 | Neither creatinine nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents |
| Q37322729 | Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function. |
| Q47807120 | New Developments in Hepatorenal Syndrome |
| Q24630646 | New loci associated with kidney function and chronic kidney disease |
| Q33532754 | Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check |
| Q47563507 | Novel Filtration Markers for GFR Estimation |
| Q37783419 | Novel Kidney Injury Biomarkers |
| Q37455337 | Obesity and change in estimated GFR among older adults. |
| Q30620940 | Occult chronic kidney disease among persons with hypertension in the United States: data from the National Health and Nutrition Surveys 1988-1994 and 1999-2002. |
| Q49954920 | On the rationale of population screening for chronic kidney disease: a public health perspective |
| Q36863889 | Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium |
| Q34861560 | Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared with matched controls |
| Q36876254 | Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis |
| Q33718114 | Performance Characteristics of Kidney Injury Molecule-1 In Relation to Creatinine, Urea, and Microalbuminuria in the Diagnosis of Kidney Disease |
| Q64065271 | Performance of 24-hour urinary creatinine excretion-estimating equations in relation to measured 24-hour urinary creatinine excretion in hospitalized hypertensive patients |
| Q37445605 | Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. |
| Q36687721 | Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals |
| Q43986995 | Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing |
| Q35549017 | Periodontitis predicts elevated C-reactive protein levels in chronic kidney disease |
| Q30569755 | Physical activity and change in estimated GFR among persons with CKD. |
| Q33885961 | Physical activity and rapid decline in kidney function among older adults |
| Q37155193 | Pitfalls in the Measurements and Assesment of Glomerular Filtration Rate and How to Escape them |
| Q37465830 | Plasma Fatty Acid binding protein 4 and risk of sudden cardiac death in older adults |
| Q35858646 | Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection |
| Q44411609 | Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients |
| Q34075458 | Plasma cystatin C and acute kidney injury after cardiopulmonary bypass |
| Q38763423 | Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis. |
| Q37448360 | Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study |
| Q33927442 | Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study |
| Q44780252 | Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease |
| Q47254043 | Population pharmacokinetics and dosing simulations of ceftazidime in Chinese neonates. |
| Q35197336 | Potassium and glucose measures in older adults: the Cardiovascular Health Study |
| Q37622270 | Predicting the glomerular filtration rate in bariatric surgery patients |
| Q40025912 | Predictive performance of glomerular filtration rate estimation equations based on cystatin C versus serum creatinine values in critically ill patients |
| Q33591588 | Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). |
| Q35175419 | Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. |
| Q37316036 | Prevalence of Reduced Kidney Function by Estimated Glomerular Filtration Rate Using an Equation Based on Creatinine and Cystatin C in Metabolic Syndrome and Its Components in Korean Adults. |
| Q34021375 | Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94). |
| Q36388998 | Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study |
| Q34736021 | Prognostic implications of microvascular and macrovascular abnormalities in older adults: cardiovascular health study |
| Q34158739 | Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz |
| Q51167762 | Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. |
| Q35108889 | Racial and ethnic differences in kidney function decline among persons without chronic kidney disease |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q37477773 | Rapid decline of kidney function increases cardiovascular risk in the elderly |
| Q33887287 | Rapid kidney function decline and mortality risk in older adults |
| Q33646576 | Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. |
| Q34572458 | Recent developments in HIV-related kidney disease |
| Q33799767 | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases |
| Q35000346 | Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM) |
| Q93609219 | References |
| Q35078542 | Relation of body mass index to urinary creatinine excretion rate in patients with coronary heart disease |
| Q37486237 | Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). |
| Q35421211 | Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study |
| Q37150714 | Relations of measures of endothelial function and kidney disease: the Framingham Heart Study |
| Q33905277 | Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes |
| Q37416394 | Relationship of urine dopamine with phosphorus homeostasis in humans: the heart and soul study |
| Q64229228 | Relative sarcopenia and mortality and the modifying effects of chronic kidney disease and adiposity |
| Q37196884 | Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation |
| Q33835691 | Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration |
| Q37089078 | Renal dysfunction in burns: a review |
| Q36813708 | Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI). |
| Q85590668 | Renal function overestimation in underweight and/or non-ambulatory patients |
| Q36510834 | Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty |
| Q30419512 | Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants |
| Q51593936 | Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort. |
| Q24633404 | Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q33718306 | Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis |
| Q33620744 | Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics |
| Q38691312 | Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease |
| Q33639802 | Screening for chronic kidney disease in HIV-infected patients |
| Q35747212 | Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study |
| Q35983519 | Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate |
| Q55476340 | Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy. |
| Q36100610 | Serum Beta 2-microglobulin/cystatin C index: a useful biomarker in lupus nephritis? |
| Q36001110 | Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients |
| Q36241451 | Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes |
| Q83821688 | Serum biochemical analysis to indicate pathogenic risk on mouse Mus musculus exposure to source of drinking water |
| Q30578167 | Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study |
| Q36334563 | Serum concentration of cystatin C and risk of end-stage renal disease in diabetes |
| Q34251828 | Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury |
| Q34414184 | Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus |
| Q35790942 | Serum cystatin C and the incidence of type 2 diabetes mellitus |
| Q83327450 | Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis |
| Q53449368 | Serum cystatin C can be used as a marker of renal function even in patients with intestinal urinary diversion. |
| Q42366536 | Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke |
| Q47579396 | Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study |
| Q35661440 | Serum cystatin C reflects the progress of albuminuria |
| Q45973807 | Serum cystatin C: a useful marker of kidney function in very old people. |
| Q37708355 | Serum cystatin-C is not superior to serum creatinine in predicting glomerular filtration rate in cirrhotic patients |
| Q37378435 | Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients |
| Q37711157 | Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA) |
| Q30876545 | Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study |
| Q35872036 | Sex differences in the prevalence and clinical outcomes of subclinical peripheral artery disease in the Health, Aging, and Body Composition (Health ABC) study |
| Q51563499 | Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. |
| Q36248461 | Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease |
| Q47586080 | Sodium bicarbonate infusion in patients undergoing orthotopic liver transplantation: a single center randomized controlled pilot trial |
| Q90279487 | Soluble CD14 and Risk of Heart Failure and its Subtypes in Older Adults |
| Q37716096 | Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study |
| Q33566795 | Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis |
| Q34587130 | Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2. |
| Q36067840 | Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis |
| Q35985806 | Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease |
| Q34447671 | Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure |
| Q36752441 | TV Watching, but Not Physical Activity, Is Associated With Change in Kidney Function in Older Adults |
| Q42561968 | Temporal trends in prevalence of CKD: the glass is half full and not half empty |
| Q34976434 | The British Columbia Nephrologists' Access Study (BCNAS) - a prospective, health services interventional study to develop waiting time benchmarks and reduce wait times for out-patient nephrology consultations |
| Q35859349 | The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function |
| Q46851869 | The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations |
| Q35060772 | The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study |
| Q35160307 | The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis |
| Q36728166 | The association of plasma cystatin C proteoforms with diabetic chronic kidney disease |
| Q33820403 | The association of uncarboxylated matrix Gla protein with mitral annular calcification differs by diabetes status: The Heart and Soul study |
| Q33769989 | The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. |
| Q37391517 | The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients |
| Q42654088 | The diagnostic value of serum creatinine and cystatin c in evaluating glomerular filtration rate in patients with chronic kidney disease: a systematic literature review and meta-analysis |
| Q37932044 | The estimation, measurement, and relevance of the glomerular filtration rate in stage 5 chronic kidney disease |
| Q37945475 | The kidney and the elderly: why does the risk increase? |
| Q39203030 | The problem of renal function monitoring in patients treated with the novel antiretroviral drugs |
| Q51627041 | The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) study estimated glomerular filtration rate. |
| Q35785324 | The risk of infection-related hospitalization with decreased kidney function |
| Q36210129 | The serum anion gap is altered in early kidney disease and associates with mortality |
| Q28301679 | Tooth loss strongly associates with malnutrition in chronic kidney disease |
| Q37022037 | Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q36299051 | Trends in the levels of urine and serum creatinine: data from NHANES 2001-2014. |
| Q37045956 | Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates |
| Q36733964 | Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study |
| Q90545669 | Uncertainty in measurement: A review of the procedures for determining uncertainty in measurement and its use in deriving the biological variation of the estimated glomerular filtration rate |
| Q38549960 | Update on Estimation of Kidney Function in Diabetic Kidney Disease. |
| Q23920029 | Uranium associations with kidney outcomes vary by urine concentration adjustment method |
| Q36988877 | Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study |
| Q39060028 | Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study |
| Q37684606 | Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS). |
| Q33749342 | Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study |
| Q34629756 | Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study |
| Q37476603 | Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury. |
| Q50950531 | Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes. |
| Q36942114 | Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes |
| Q36431302 | Urinary markers of kidney injury and kidney function decline in HIV-infected women |
| Q36299917 | Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults |
| Q36104818 | Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study |
| Q36438126 | Urine calcium excretion, cardiovascular events, and mortality in outpatients with stable coronary artery disease (from the Heart and Soul study). |
| Q37876853 | Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications |
| Q33793556 | Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease |
| Q46017056 | Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. |
| Q40837133 | Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women |
| Q37014745 | Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate |
| Q40749182 | Validation of cystatin C-based equations for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis |
| Q59100846 | Variability in estimated glomerular filtration rate by area under the curve predicts renal outcomes in chronic kidney disease |
| Q37211081 | Vitamin D affects survival independently of vascular calcification in chronic kidney disease |
| Q35534744 | Vitamin D, parathyroid hormone, and cardiovascular events among older adults |
| Q34238435 | Warfarin dosing in patients with impaired kidney function |
| Q36771949 | Within-person variability in kidney measures |
| Q34354535 | Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions |
| Q46107442 | an Obituary for GFR as the main marker for kidney function? |
Search more.